Health News Releases

  • Today May 18
March 11, 2019 10:10
New ESMO Guidelines Include FOTIVDA®▼(tivozanib) Recommendation for Patients with Advanced Renal Cell Carcinoma
HEMEL HEMPSTEAD, England--(BUSINESS WIRE)-- EUSA Pharma (EUSA) welcomes the news that FOTIVDA®▼ (tivozanib) has been included in the new European Society of Medical Oncology (ESMO) clinical practice g
March 11, 2019 10:00
Galderma Presented Final Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting Late-Breaking Session
Galderma, Nestlé Skin Health’s medical solutions business, presented the final results from a Phase 2b dose-ranging study of nemolizumab, an investigational therapy in adult patients with moderate-to-
March 08, 2019 18:50
Mindray Signs Patient Safety Movement’s Open Data Pledge & Becomes 90th Company to Join to Improve Patient Safety
The Patient Safety Movement Foundation (PSMF) announced today that the global medical device developer and manufacturer Mindray has become the 90th company to sign the PSMF’s Open Data Pledge, demonst
March 08, 2019 17:40
ResMed Acquires HB Healthcare to Help Millions of Koreans Living with Sleep Apnea, Other Respiratory Conditions
ResMed (NYSE: RMD, ASX: RMD), a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, today announced that is has completed the acquisition of HB Healthcare (
March 08, 2019 16:55
Carestream Health to Sell Its Healthcare IT Business to Philips
Carestream Health has signed an agreement with Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, to sell its healthcare information systems (HCIS) business to Philips. Car
March 08, 2019 13:25
Impossible Foods Continues Asian Expansion in Singapore
Impossible Foods is launching its plant-based meat Thursday, 7 March, with a variety of dishes available at eight restaurants throughout Singapore -- one of the world’s most vibrant and discerning cul
March 05, 2019 17:00
Masimo Announces CE Marking of Pediatric Indication for Next Generation SedLine® Brain Function Monitoring
Masimo (NASDAQ: MASI) announced today the CE marking of Next Generation SedLine® brain function monitoring for pediatric patients (1-18 years of age). With this clearance, the benefits of Next Generat
February 27, 2019 11:05
Boehringer Ingelheim and GNA Biosolutions partner on emergency veterinary diagnostics development
Boehringer Ingelheim and GNA Biosolutions announce that they have entered into a research collaboration focused on the development of a rapid African swine fever (ASF) diagnostic test. The test would
February 26, 2019 20:00
LMD’s Smartphone-Integrated e-Checkup™ System Makes Medically-Accurate Personal Health Monitoring a Reality
Leman Micro Devices (LMD), the developer of regulated consumer healthcare products that is backed by major players within the mobile device industry, has announced that e-Checkup™ is now poised to be
February 26, 2019 11:40
New Case Series Investigates the Combined Use of Masimo SedLine® Brain Function Monitoring and O3® Regional Oximetry During Cardiac Surgery
Masimo (NASDAQ: MASI) announced today the findings of a series of four clinical cases, recently published in the Canadian Journal of Anesthesiology, in which researchers at the University of Montreal
February 25, 2019 09:50
Mundipharma EDO GmbH: US FDA grants Orphan Drug Designation for etoposide toniribate in relapsed/refractory biliary tract cancer
Mundipharma EDO GmbH, part of the Mundipharma network of independent associated companies, and Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., today announced that the US FDA
February 21, 2019 16:00
ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation
ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent infringement disputes between the companies in all venue
February 21, 2019 13:35
KCI Launches ABTHERA™ Therapy in Japan
KCI, an Acelity Company, today announced the launch of ABTHERA™ Open Abdomen Negative Pressure Therapy in Japan, expanding access to the Company’s surgical portfolio in the country. ABTHERA™ Therapy i
February 19, 2019 16:50
Boehringer Ingelheim and Lilly’s CAROLINA® cardiovascular outcome trial for Trajenta® meets primary endpoint of non-inferiority compared to glimepiride
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) announced CAROLINA® (CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with type 2 diabetes) met its primary endpoin
February 19, 2019 13:45
Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology
Recently at Arab Health 2019, the Saudi Arabia Ministry of Health (MOH) and Masimo (NASDAQ: MASI) jointly announced the implementation of an automation solution designed to streamline the process of c
February 14, 2019 11:40
SpeeDx Develops Multiplex Test for Respiratory Viruses
SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the Australian 2019 flu seaso
Dr. Yumi Jung is explaining gum and mouth condition to patients through digital scanning
February 13, 2019 09:50
Clean management of Laser Gum Bleaching with Dr. Yumi Jung of MAGIC KISS Dental Clinic in Korea
When someone mentions whitening (Bleaching), you will usually think of whitening of the teeth or face. But some people are worried about their black or dark gums. So, Dr. Yumi Jung, the chief denti
February 12, 2019 16:50
European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) extended the current marketing authorization of ADCETRIS (brentuximab vedotin) to include tr
February 08, 2019 11:20
Takeda Announces Results from First-of-Its-Kind Phase IIIb/IV Trial PROPEL - a Randomized PK-Guided Prophylaxis Study Evaluating Higher Factor VIII Levels in Hemophilia A- at EAHAD 2019
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”), the global biotechnology leader in rare diseases, has today announced results from its phase IIIb/IV clinical trial for ADYNOVATE
February 04, 2019 13:50
Takeda Reports Third Quarter FY2018 Results
Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK): Underlying Revenue +4.8% year-to-date with growth of prescription drug portfolio in all regions · Solid Underlying Revenue growth of
February 01, 2019 13:28
G+FLAS Life Sciences, a Korean CRISPR/Cas Genome Editing Company, Licenses DNA-Free Genome Editing Technologies
G+FLAS Life Sciences, Inc. (G+FLAS), a CRISPR/Cas genome editing company in South Korea, announced that they licensed two patents regarding Non-GMO ways of plant genome engineering. The licensed DNA-f
February 01, 2019 11:45
Takeda Scoops Prestigious Global Top Employers® Award for Second Year Running
Takeda Pharmaceutical Company Limited [TOKYO: 4502 / NYSE: TAK], (“Takeda”) today announced it has become part of a select group of only 12 to receive global Top Employer® status for 2019. Established
January 31, 2019 18:25
Morinaga Milk's Probiotic Bifidobacterium infantis M-63 Alleviates Mental Stress of Flood Victims
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced new research showing that consumption of its proprietary probiotic Morinaga Bifidobacterium inf
January 31, 2019 18:10
Bioventus Launches DUROLANE® in Malaysia and Selects Athrotech as Exclusive Distribution Partner
Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE, its single-injection joint-fluid osteoarthritis (OA) treatment, in Malaysia and has selected Athrotech as its exclusive di
January 30, 2019 13:45
Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
Takeda Pharmaceutical Company Limited [TSE:4502 / NYSE:TAK] (“Takeda”) today announced that the pivotal Phase 3 trial of its dengue vaccine candidate met the primary efficacy endpoint. This first anal
25 per page50 per page75 per page100 per page